ACTIVITY TITLE
Myanmar (le): Pentavalent
Myanmar: Pentavalent
Reported by
| ACTIVITY SCOPE | COLLABORATION TYPE | AID TYPE | FINANCE TYPE | FLOW TYPE | TIED STATUS | HIERARCHY |
|---|---|---|---|---|---|---|
| National 4 | Multilateral (inflows) 2 |
Project-type interventions C01
|
Standard grant 110 | ODA 10 | Untied | 2 |
DOCUMENTS ( 16 )
Proposal for NVS - Penta support: Myanmar
APPLICATION/MSWORD
EN
Pre- and post-project impact appraisal
Objectives / Purpose of activity
Intended ultimate beneficiaries
Memorandum of understanding (If agreed by all parties)
Proposal for NVS - Penta support: Myanmar
APPLICATION/MSWORD
EN
Pre- and post-project impact appraisal
Objectives / Purpose of activity
Intended ultimate beneficiaries
Memorandum of understanding (If agreed by all parties)
Pentavalent vaccine support
TEXT/HTML
EN
Objectives / Purpose of activity
Intended ultimate beneficiaries
Activity web page
Soutien au vaccin pentavalent
TEXT/HTML
FR
Objectives / Purpose of activity
Intended ultimate beneficiaries
Activity web page
Decision Letter NVS Myanmar 2014(3)
APPLICATION/PDF
EN
2014-12-31
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter NVS Myanmar 2014(3)
APPLICATION/PDF
EN
2014-12-31
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter NVS Myanmar 2016 (4)
APPLICATION/PDF
EN
2016-12-31
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter NVS Myanmar 2016 (4)
APPLICATION/PDF
EN
2016-12-31
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter NVS Myanmar 2017 (2)
APPLICATION/PDF
EN
2017-12-31
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter NVS Myanmar 2017 (2)
APPLICATION/PDF
EN
2017-12-31
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter NVS Myanmar 2017 (5)
APPLICATION/PDF
EN
2017-12-31
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter NVS Myanmar 2017 (5)
APPLICATION/PDF
EN
2017-12-31
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter PENTA Myanmar 2019
APPLICATION/PDF
EN
2019-03-03
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter PENTA Myanmar 2020
APPLICATION/PDF
EN
2020-03-03
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter PENTA Myanmar 2022
APPLICATION/PDF
EN
2022-03-03
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Decision Letter PENTA Myanmar 2023
APPLICATION/PDF
EN
2023-03-03
Conditions
Budget
Summary information about contract
Memorandum of understanding (If agreed by all parties)
Contract
Planned start date 2012-01-01
Planned end date 2026-12-31
Actual start date 2012-01-01
activity status: Implementation
The activity is currently being implemented
WHO'S INVOLVED ( 4 )
| PARTICIPATING ORG | REFERENCE | ROLE | TYPE |
|---|---|---|---|
Gavi, The Vaccine Alliance
|
REF 47122
|
Funding | Multilateral |
The Government of Myanmar
|
Implementing | Government | |
UNICEF Supply Division
|
REF XM-DAC-41122
|
Implementing | Multilateral |
World Health Organisation (WHO)
|
REF XM-DAC-928
|
Implementing | Multilateral |
Other
Cette activité détaille notre travail sur le Pentavalent en Myanmar (le), grâce à la mise à disposition des données budgétaires et des transactions. Nous fournissons également les documents pertinents qui guident ces activités que sont les formulaires de demande de soutien fournis par le gouvernement de Myanmar (le) ainsi que les lettres de décisions émises par Gavi, pour progresser. Ces documents décrivent les activités, les objectifs ainsi que les bénéficiaires.
This activity details our work on Pentavalent in Myanmar through the provision of budget and transaction data. We also provide the relevant documents that guide these activities, which are the support request proposal(s) provided by the Government of Myanmar, as well as the decision letter(s) issued by Gavi, for progress. These documents describe the activities, the objectives as well as the beneficiaries.
General
GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. The pentavalent vaccine, administered in a three-dose schedule, offers protection against five diseases: diphtheria-tetanus-pertussis (DTP), heptatitis B and Haemophilius influenzae type b. Until 2013, GAVI has helped to introduce the pentavalent in 70 of the 73 GAVI-eligible countries, with the aim of reaching all 73 by the end of 2014. GAVI support for pentavalent vaccine is in line with WHO recommendations, for routine infant immunisation and primarily targeting children under one year of age.
Garantir la fiabilité et la pérennité des approvisionnements en vaccins pentavalent à des prix abordables. Une Vaccination systematique et une une aide au financement des vaccins antidiphtérique-antitétanique-anticoquelucheux (DTC), anti-hépatite B et anti-Haemophilius influenzae type b (Hib) depuis sa création. Cependant, pour remédier à la faible demande historique du vaccin anti-Hib dans nombre de pays, Gavi a également commencé à offrir le vaccin pentavalent en 2001. L’objectif était d’élargir la couverture par l’ajout des vaccins anti-Hib et anti-hépatite B dans le cadre de la vaccination systématique. En 2012, Gavi a décidé de n’attribuer une aide au financement des vaccins anti-hépatite B et anti-Hib que si ceux-ci étaient administrés au moyen du vaccin pentavalent cinq-en-un.
Le pentavalent contient cinq vaccins différents dans une fiole et protège donc de cinq maladies : diphtérie, coqueluche, tétanos (DTC), hépatite B et Haemophilus influenzae type B (Hib).
Successeur du vaccin DTC, il a été introduit pour accroître la couverture des vaccins anti-hépatite B et anti-Hib en les ajoutant au programme de vaccination systématique.
tag( 14 )
| DESCRIPTION | CODE | VOCABULARY |
|---|---|---|
|
Pentavalent Pentavalent
Pentavalent Pentavalent
|
PENTA | Reporting Organisation |
| Goal 1. End poverty in all its forms everywhere | 1 | UN Sustainable Development Goals (SDG) |
| Goal 10. Reduce inequality within and among countries | 10 | UN Sustainable Development Goals (SDG) |
| Goal 11. Make cities and human settlements inclusive, safe, resilient and sustainable | 11 | UN Sustainable Development Goals (SDG) |
| Goal 13. Take urgent action to combat climate change and its impacts | 13 | UN Sustainable Development Goals (SDG) |
| Goal 16. Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levels | 16 | UN Sustainable Development Goals (SDG) |
| Goal 17. Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development | 17 | UN Sustainable Development Goals (SDG) |
| Goal 2. End hunger, achieve food security and improved nutrition and promote sustainable agriculture | 2 | UN Sustainable Development Goals (SDG) |
| Goal 3. Ensure healthy lives and promote well-being for all at all ages | 3 | UN Sustainable Development Goals (SDG) |
| Goal 4. Ensure inclusive and equitable quality education and promote lifelong learning opportunities for all | 4 | UN Sustainable Development Goals (SDG) |
| Goal 5. Achieve gender equality and empower all women and girls | 5 | UN Sustainable Development Goals (SDG) |
| Goal 7. Ensure access to affordable, reliable, sustainable and modern energy for all | 7 | UN Sustainable Development Goals (SDG) |
| Goal 8. Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all | 8 | UN Sustainable Development Goals (SDG) |
| Goal 9. Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation | 9 | UN Sustainable Development Goals (SDG) |
policy marker( 2 )
| CODELIST | SIGNIFICANCE | VOCABULARY | DESCRIPTION |
|---|---|---|---|
| Gender Equality | principal objective | OECD DAC CRS | Principal (primary) policy objectives are those which can be identified as being fundamental in the design and impact of the activity and which are an explicit objective of the activity. They may be selected by answering the question "Would the activity have been undertaken without this objective?" |
| Reproductive, Maternal, Newborn and Child Health (RMNCH) | principal objective | OECD DAC CRS | Principal (primary) policy objectives are those which can be identified as being fundamental in the design and impact of the activity and which are an explicit objective of the activity. They may be selected by answering the question "Would the activity have been undertaken without this objective?" |
LOCATION ( 1 )
| NAME | DESCRIPTION | POSITION | CLASS | REACH | EXACTNESS |
|---|---|---|---|---|---|
|
ID MM (ISO Country (3166-1 alpha-2))
|
Administrative Region |
Financial Overview
Outgoing Commitment ( 20 )
Disbursement ( 70 )
Outgoing Pledge ( 3 )
Budget ( 68 )
Outgoing Commitment
Disbursement
Outgoing Pledge
Budget
Budget ( 68 )
| START | END | TYPE | STATUS | VALUE |
|---|---|---|---|---|
| 2012-01-01 | 2012-03-31 | Revised | Committed | 1,691,240.7 USD |
| 2012-01-01 | 2012-03-31 | Original | Indicative | 302,250 USD |
| 2012-04-01 | 2012-06-30 | Revised | Committed | 1,691,240.7 USD |
| 2012-04-01 | 2012-06-30 | Original | Indicative | 302,250 USD |
| 2012-07-01 | 2012-09-30 | Revised | Committed | 1,691,240.7 USD |
| 2012-07-01 | 2012-09-30 | Original | Indicative | 302,250 USD |
| 2012-10-01 | 2012-12-31 | Revised | Committed | 1,691,240.7 USD |
| 2012-10-01 | 2012-12-31 | Original | Indicative | 302,250 USD |
| 2013-01-01 | 2013-03-31 | Revised | Committed | 2,592,395.785 USD |
| 2013-04-01 | 2013-06-30 | Revised | Committed | 2,592,395.785 USD |
| 2013-07-01 | 2013-09-30 | Revised | Committed | 2,592,395.785 USD |
| 2013-10-01 | 2013-12-31 | Revised | Committed | 2,592,395.785 USD |
| 2014-01-01 | 2014-03-31 | Revised | Committed | 1,580,194.648 USD |
| 2014-04-01 | 2014-06-30 | Revised | Committed | 1,580,194.648 USD |
| 2014-07-01 | 2014-09-30 | Revised | Committed | 1,580,194.648 USD |
| 2014-10-01 | 2014-12-31 | Revised | Committed | 1,580,194.648 USD |
| 2015-01-01 | 2015-03-31 | Revised | Committed | 1,279,781.288 USD |
| 2015-04-01 | 2015-06-30 | Revised | Committed | 1,279,781.288 USD |
| 2015-07-01 | 2015-09-30 | Revised | Committed | 1,279,781.288 USD |
| 2015-10-01 | 2015-12-31 | Revised | Committed | 1,279,781.288 USD |
| 2016-01-01 | 2016-03-31 | Revised | Committed | 25,864.45 USD |
| 2016-04-01 | 2016-06-30 | Revised | Committed | 25,864.45 USD |
| 2016-07-01 | 2016-09-30 | Revised | Committed | 25,864.45 USD |
| 2016-10-01 | 2016-12-31 | Revised | Committed | 25,864.45 USD |
| 2017-01-01 | 2017-03-31 | Revised | Committed | 625,644.1525 USD |
| 2017-04-01 | 2017-06-30 | Revised | Committed | 625,644.1525 USD |
| 2017-07-01 | 2017-09-30 | Revised | Committed | 625,644.1525 USD |
| 2017-10-01 | 2017-12-31 | Revised | Committed | 625,644.1525 USD |
| 2018-01-01 | 2018-03-31 | Revised | Committed | 398,750 USD |
| 2018-04-01 | 2018-06-30 | Revised | Committed | 398,750 USD |
| 2018-07-01 | 2018-09-30 | Revised | Committed | 398,750 USD |
| 2018-10-01 | 2018-12-31 | Revised | Committed | 398,750 USD |
| 2019-01-01 | 2019-03-31 | Revised | Committed | 264,324.9575 USD |
| 2019-04-01 | 2019-06-30 | Revised | Committed | 264,324.9575 USD |
| 2019-07-01 | 2019-09-30 | Revised | Committed | 264,324.9575 USD |
| 2019-10-01 | 2019-12-31 | Revised | Committed | 264,324.9575 USD |
| 2020-01-01 | 2020-03-31 | Revised | Committed | 453,740.6325 USD |
| 2020-04-01 | 2020-06-30 | Revised | Committed | 453,740.6325 USD |
| 2020-07-01 | 2020-09-30 | Revised | Committed | 453,740.6325 USD |
| 2020-10-01 | 2020-12-31 | Revised | Committed | 453,740.6325 USD |
| 2021-01-01 | 2021-03-31 | Revised | Committed | 681,063.2425 USD |
| 2021-01-01 | 2021-03-31 | Original | Indicative | 567,875 USD |
| 2021-04-01 | 2021-06-30 | Revised | Committed | 681,063.2425 USD |
| 2021-04-01 | 2021-06-30 | Original | Indicative | 567,875 USD |
| 2021-07-01 | 2021-09-30 | Revised | Committed | 681,063.2425 USD |
| 2021-07-01 | 2021-09-30 | Original | Indicative | 567,875 USD |
| 2021-10-01 | 2021-12-31 | Revised | Committed | 681,063.2425 USD |
| 2021-10-01 | 2021-12-31 | Original | Indicative | 567,875 USD |
| 2022-01-01 | 2022-03-31 | Revised | Committed | 428,497.35 USD |
| 2022-04-01 | 2022-06-30 | Revised | Committed | 428,497.35 USD |
| 2022-07-01 | 2022-09-30 | Revised | Committed | 428,497.35 USD |
| 2022-10-01 | 2022-12-31 | Revised | Committed | 428,497.35 USD |
| 2023-01-01 | 2023-03-31 | Revised | Committed | 385,547.3725 USD |
| 2023-04-01 | 2023-06-30 | Revised | Committed | 385,547.3725 USD |
| 2023-07-01 | 2023-09-30 | Revised | Committed | 385,547.3725 USD |
| 2023-10-01 | 2023-12-31 | Revised | Committed | 385,547.3725 USD |
| 2024-01-01 | 2024-03-31 | Revised | Committed | 1,017,404.478 USD |
| 2024-04-01 | 2024-06-30 | Revised | Committed | 1,017,404.478 USD |
| 2024-07-01 | 2024-09-30 | Revised | Committed | 1,017,404.478 USD |
| 2024-10-01 | 2024-12-31 | Revised | Committed | 1,017,404.478 USD |
| 2025-01-01 | 2025-03-31 | Revised | Committed | 486,077.9375 USD |
| 2025-04-01 | 2025-06-30 | Revised | Committed | 486,077.9375 USD |
| 2025-07-01 | 2025-09-30 | Revised | Committed | 486,077.9375 USD |
| 2025-10-01 | 2025-12-31 | Revised | Committed | 486,077.9375 USD |
| 2026-01-01 | 2026-03-31 | Revised | Committed | 451,099.265 USD |
| 2026-04-01 | 2026-06-30 | Revised | Committed | 451,099.265 USD |
| 2026-07-01 | 2026-09-30 | Revised | Committed | 451,099.265 USD |
| 2026-10-01 | 2026-12-31 | Revised | Committed | 451,099.265 USD |
Budget
Transactions ( 93 )
Outgoing Commitment ( 20 )
| DATE | DESCRIPTION | PROVIDER | RECEIVER | VALUE |
|---|---|---|---|---|
| 2012-01-01 |
Approved 2012 budget for Myanmar PENTA, Implementor: WHO, Type of Support: VIG, Commitment item: 600021 Cash-based programs
REF MMRPENTA2012
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
World Health Organisation (WHO)
REF XM-DAC-928
Multilateral
|
1,209,000 USD |
| 2012-01-01 |
Approved 2012 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2012
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
5,555,962.8 USD |
| 2013-01-01 |
Approved 2013 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2013
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
10,369,583.14 USD |
| 2014-01-01 |
Approved 2014 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2014
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
6,320,778.59 USD |
| 2015-01-01 |
Approved 2015 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2015
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
5,119,125.15 USD |
| 2016-01-01 |
Approved 2016 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2016
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
103,457.8 USD |
| 2017-01-01 |
Approved 2017 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2017
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
2,502,576.61 USD |
| 2018-01-01 |
Approved 2018 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2018
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
1,595,000 USD |
| 2019-01-01 |
Approved 2019 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2019
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
-4,315 USD |
| 2019-01-01 |
Approved 2019 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2019
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
1,067,500 USD |
| 2019-01-01 |
Approved 2019 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600026 Refunds of program expenses
REF MMRPENTA2019
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
-5,885.17 USD |
| 2020-01-01 |
Approved 2020 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2020
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
-43,037.47 USD |
| 2020-01-01 |
Approved 2020 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2020
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
1,760,500 USD |
| 2020-01-01 |
Approved 2020 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2020
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
97,500 USD |
| 2021-01-01 |
Approved 2021 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2021
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
2,724,252.97 USD |
| 2022-01-01 |
Approved 2022 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2022
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
1,713,989.4 USD |
| 2023-01-01 |
Approved 2023 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2023
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
1,542,189.49 USD |
| 2024-01-01 |
Approved 2024 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2024
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
4,069,617.91 USD |
| 2025-01-01 |
Approved 2025 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2025
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
1,944,311.75 USD |
| 2026-01-01 |
Approved 2026 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2026
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
1,804,397.06 USD |
Outgoing Commitment
Disbursement ( 70 )
| DATE | DESCRIPTION | PROVIDER | RECEIVER | VALUE |
|---|---|---|---|---|
| 2012-06-07 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
6,120,703 USD |
| 2012-11-05 |
Cash disbursement for programme MMR-PENTA-R-VIG-WHO
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
World Health Organisation (WHO)
REF XM-DAC-928
Multilateral
|
1,209,000 USD |
| 2012-12-17 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
6,076,155 USD |
| 2013-04-11 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
5,104,913 USD |
| 2013-06-24 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-564,740.2 USD |
| 2013-12-13 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
233,202 USD |
| 2014-01-21 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
250,000 USD |
| 2014-07-03 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-656,720 USD |
| 2014-10-02 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
473,414 USD |
| 2014-12-03 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
153,606 USD |
| 2015-03-30 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,747,700 USD |
| 2015-04-16 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,373,300 USD |
| 2015-06-03 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-1,031,784.86 USD |
| 2015-07-16 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,530,065 USD |
| 2015-09-14 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
0 USD |
| 2015-09-22 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
232,572.25 USD |
| 2015-11-05 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,508,202 USD |
| 2015-12-16 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
10,000 USD |
| 2016-02-10 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
164,935.5 USD |
| 2016-05-03 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-71,690.41 USD |
| 2016-05-18 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,508,384 USD |
| 2016-07-13 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
2,738,386 USD |
| 2017-03-02 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
723,765 USD |
| 2017-08-29 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-93,982.11 USD |
| 2017-08-29 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-61,477.7 USD |
| 2017-08-29 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
697,834 USD |
| 2017-11-08 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
734,837 USD |
| 2018-03-08 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,077,831 USD |
| 2018-07-11 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,373,183 USD |
| 2018-09-06 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-650,000 USD |
| 2018-11-07 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-7,925.39 USD |
| 2019-03-25 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
708,556 USD |
| 2019-05-22 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,063,185 USD |
| 2019-09-06 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-26,244.81 USD |
| 2019-11-29 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100000599
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
922,500 USD |
| 2020-01-24 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100003412
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-922,500 USD |
| 2020-02-28 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100000470
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
136,731.12 USD |
| 2020-03-31 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 700001198
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-922,500 USD |
| 2020-04-24 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100001601
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
367,906 USD |
| 2020-05-15 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 1700000010
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-5,885.17 USD |
| 2020-08-20 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100003441
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-44,372.86 USD |
| 2020-08-26 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100003430
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,356,961 USD |
| 2021-01-27 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100000249
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
207,610 USD |
| 2021-02-03 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100000275
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,283,987 USD |
| 2021-04-30 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100002057
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
10,049.05 USD |
| 2022-05-25 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100003725
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,339,405 USD |
| 2022-06-03 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100003729
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
134,105 USD |
| 2022-07-15 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100005432
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-14,479.5 USD |
| 2022-10-14 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100007809
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
807,000 USD |
| 2022-12-16 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100010376
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
897,390 USD |
| 2023-02-09 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100001221
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-48,015 USD |
| 2023-03-27 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100002169
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-89,313.62 USD |
| 2023-04-27 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100003252
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-48,334.85 USD |
| 2023-05-19 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100003742
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-76,350 USD |
| 2023-07-31 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100005713
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,457,070 USD |
| 2023-08-04 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100005711
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
9,850 USD |
| 2023-08-16 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100006036
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
135,212 USD |
| 2024-02-28 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100009607
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
865,000 USD |
| 2024-06-14 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100002953
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
885,066.5 USD |
| 2024-07-31 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100003918
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
126,903.64 USD |
| 2024-08-30 |
Vaccine disbursement for programme MMR-PENTA-BCU-VAC
REF 5100004926
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
2,377,977 USD |
| 2024-12-13 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100009888
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-68,040.68 USD |
| 2025-02-21 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100001508
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-151,672.5 USD |
| 2025-06-13 |
Vaccine disbursement for programme MMR-PENTA-BCU-VAC
REF 5100002097
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
127,588.75 USD |
| 2025-06-20 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100003223
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
97,862.75 USD |
| 2025-06-24 |
Vaccine disbursement for programme MMR-PENTA-BCU-VAC
REF 5100004591
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-3,065.71 USD |
| 2025-06-24 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100004591
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-2,283.47 USD |
| 2025-08-19 |
Vaccine disbursement for programme MMR-PENTA-BCU-VAC
REF 5100006024
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
-346,959 USD |
| 2025-11-17 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100006364
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
1,834,250.5 USD |
| 2026-03-06 |
Vaccine disbursement for programme MMR-PENTA-R-VAC
REF 5100010048
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
UNICEF Supply Division
REF XM-DAC-41122
Multilateral
|
81,877.06 USD |
Disbursement
Outgoing Pledge ( 3 )
| DATE | DESCRIPTION | PROVIDER | RECEIVER | VALUE |
|---|---|---|---|---|
| 2012-01-01 |
Endorsed 2012 budget for Myanmar PENTA, Type of Support: VIG, Commitment item: 600021 Cash-based programs
REF MMRPENTA2012
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
1,209,000 USD |
| 2021-01-01 |
Endorsed 2021 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2021
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
119,000 USD |
| 2021-01-01 |
Endorsed 2021 budget for Myanmar PENTA, Type of Support: VAC, Commitment item: 600022 Vaccine programs
REF MMRPENTA2021
SECTOR DAC Infectious disease control 12250
COUNTRY Myanmar MM
|
Gavi, The Vaccine Alliance
REF 47122
Multilateral
|
The Government of Myanmar
Government
|
2,152,500 USD |
Outgoing Funds
related activity( 1 )
experimental! view network
| REFERENCE IDENTIFIER | TYPE | DESCRIPTION |
|---|---|---|
| 47122-MMR | Parent | An activity that contains sub-activities (sub-components) which are reported separately to IATI |
other identifier( 4 )
| REFERENCE IDENTIFIER | OWNER ORG IDENTIFIER | TYPE | DESCRIPTION |
|---|---|---|---|
| 47122 |
47122
Gavi, The Vaccine Alliance |
Previous Reporting Organisation Identifier
CODE B1
|
No description provided |
| 47122-12-MMR-08B-Y |
Previous Activity Identifier
CODE A3
|
The standard insists that once an activity has been reported to IATI its identifier MUST NOT be changed, even if the reporting organisation changes its organisation identifier. There may be exceptional circumstances in which this rule cannot be followed, in which case the previous identifier should be reported using this code. | |
| 47122-1216-MMR-04C-X |
Previous Activity Identifier
CODE A3
|
The standard insists that once an activity has been reported to IATI its identifier MUST NOT be changed, even if the reporting organisation changes its organisation identifier. There may be exceptional circumstances in which this rule cannot be followed, in which case the previous identifier should be reported using this code. | |
| 47122-1721-MMR-04C-X |
Previous Activity Identifier
CODE A3
|
The standard insists that once an activity has been reported to IATI its identifier MUST NOT be changed, even if the reporting organisation changes its organisation identifier. There may be exceptional circumstances in which this rule cannot be followed, in which case the previous identifier should be reported using this code. |
conditions( 1 )
| NARRATIVE | TYPE | DESCRIPTION |
|---|---|---|
Conditions are available in the decision letters
|
Fiduciary | The condition attached requires use of certain public financial management or public accountability measures by the recipient |